Integration of Pharmaceutical Discovery and Development: Case Histories (Pharmaceutical Biotechnology)

0 avg rating
( 0 ratings by Goodreads )
 
9780306457432: Integration of Pharmaceutical Discovery and Development: Case Histories (Pharmaceutical Biotechnology)
View all copies of this ISBN edition:
 
 

In the late 1980s, it became painfully evident to the pharmaceutical industry that the old paradigm of drug discovery, which involved highly segmented drug - sign and development activities, would not produce an acceptable success rate in the future. Therefore, in the early 1990s a paradigm shift occurred in which drug design and development activities became more highly integrated. This new str- egy required medicinal chemists to design drug candidates with structural f- tures that optimized pharmacological (e. g. , high affinity and specificity for the target receptor), pharmaceutical (e. g. , solubility and chemical stability), bioph- maceutical (e. g. , cell membrane permeability), and metabolic/pharmacokinetic (e. g. , metabolic stability, clearance, and protein binding) properties. Successful implementation of this strategy requires a multidisciplinary team effort, incl- ing scientists from drug design (e. g. , medicinal chemists, cell biologists, en- mologists, pharmacologists) and drug development (e. g. , analytical chemists, pharmaceutical scientists, physiologists, and molecular biologists representing the disciplines of pharmaceutics, biopharmaceutics, and pharmacokinetics/drug metabolism). With this new, highly integrated approach to drug design now widely utilized by the pharmaceutical industry, the editors of this book have provided the sci- tific community with case histories to illustrate the nature of the interdisciplinary interactions necessary to successfully implement this new approach to drug d- covery. In the first chapter, Ralph Hirschmann provides a historical perspective of why this paradigm shift in drug discovery has occurred.

"synopsis" may belong to another edition of this title.

Buy New View Book
List Price: US$ 349.99
US$ 225.17

Convert currency

Shipping: US$ 4.95
Within U.S.A.

Destination, rates & speeds

Add to Basket

Other Popular Editions of the Same Title

9781441932884: Integration of Pharmaceutical Discovery and Development: Case Histories (Pharmaceutical Biotechnology)

Featured Edition

ISBN 10:  1441932887 ISBN 13:  9781441932884
Publisher: Springer, 2010
Softcover

Top Search Results from the AbeBooks Marketplace

1.

ISBN 10: 0306457431 ISBN 13: 9780306457432
New Quantity Available: 1
Seller:
BennettBooksLtd
(San Diego, CA, U.S.A.)
Rating
[?]

Book Description Condition: New. New. Seller Inventory # STR-0306457431

More information about this seller | Contact this seller

Buy New
US$ 225.17
Convert currency

Add to Basket

Shipping: US$ 4.95
Within U.S.A.
Destination, rates & speeds

2.

Published by Springer Science+Business Media, United States (1998)
ISBN 10: 0306457431 ISBN 13: 9780306457432
New Hardcover Quantity Available: 10
Seller:
Book Depository hard to find
(London, United Kingdom)
Rating
[?]

Book Description Springer Science+Business Media, United States, 1998. Hardback. Condition: New. 1998 ed.. Language: English. Brand new Book. In the late 1980s, it became painfully evident to the pharmaceutical industry that the old paradigm of drug discovery, which involved highly segmented drug - sign and development activities, would not produce an acceptable success rate in the future. Therefore, in the early 1990s a paradigm shift occurred in which drug design and development activities became more highly integrated. This new str- egy required medicinal chemists to design drug candidates with structural f- tures that optimized pharmacological (e. g. , high affinity and specificity for the target receptor), pharmaceutical (e. g. , solubility and chemical stability), bioph- maceutical (e. g. , cell membrane permeability), and metabolic/pharmacokinetic (e. g. , metabolic stability, clearance, and protein binding) properties. Successful implementation of this strategy requires a multidisciplinary team effort, incl- ing scientists from drug design (e. g. , medicinal chemists, cell biologists, en- mologists, pharmacologists) and drug development (e. g. , analytical chemists, pharmaceutical scientists, physiologists, and molecular biologists representing the disciplines of pharmaceutics, biopharmaceutics, and pharmacokinetics/drug metabolism). With this new, highly integrated approach to drug design now widely utilized by the pharmaceutical industry, the editors of this book have provided the sci- tific community with case histories to illustrate the nature of the interdisciplinary interactions necessary to successfully implement this new approach to drug d- covery. In the first chapter, Ralph Hirschmann provides a historical perspective of why this paradigm shift in drug discovery has occurred. Seller Inventory # LIE9780306457432

More information about this seller | Contact this seller

Buy New
US$ 300.98
Convert currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, rates & speeds

3.

Borchardt, Ronald T.
Published by Springer (2016)
ISBN 10: 0306457431 ISBN 13: 9780306457432
New Paperback Quantity Available: 1
Print on Demand
Seller:
Ria Christie Collections
(Uxbridge, United Kingdom)
Rating
[?]

Book Description Springer, 2016. Paperback. Condition: New. PRINT ON DEMAND Book; New; Publication Year 2016; Not Signed; Fast Shipping from the UK. No. book. Seller Inventory # ria9780306457432_lsuk

More information about this seller | Contact this seller

Buy New
US$ 329.40
Convert currency

Add to Basket

Shipping: US$ 5.05
From United Kingdom to U.S.A.
Destination, rates & speeds

4.

Ronald T. Borchardt
Published by Springer Science+Business Media (1998)
ISBN 10: 0306457431 ISBN 13: 9780306457432
New Quantity Available: > 20
Print on Demand
Seller:
Books2Anywhere
(Fairford, GLOS, United Kingdom)
Rating
[?]

Book Description Springer Science+Business Media, 1998. HRD. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # IQ-9780306457432

More information about this seller | Contact this seller

Buy New
US$ 368.41
Convert currency

Add to Basket

Shipping: US$ 11.75
From United Kingdom to U.S.A.
Destination, rates & speeds

5.

RONALD T. BORCHARDT
Published by Springer (1998)
ISBN 10: 0306457431 ISBN 13: 9780306457432
New Hardcover Quantity Available: 1
Seller:
Herb Tandree Philosophy Books
(Stroud, GLOS, United Kingdom)
Rating
[?]

Book Description Springer, 1998. Hardback. Condition: NEW. 9780306457432 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. For all enquiries, please contact Herb Tandree Philosophy Books directly - customer service is our primary goal. Seller Inventory # HTANDREE0270319

More information about this seller | Contact this seller

Buy New
US$ 369.91
Convert currency

Add to Basket

Shipping: US$ 10.42
From United Kingdom to U.S.A.
Destination, rates & speeds

6.

Borchardt, Ronald T.
Published by Springer Science+Business Media (1998)
ISBN 10: 0306457431 ISBN 13: 9780306457432
New Quantity Available: > 20
Print on Demand
Seller:
Pbshop
(Wood Dale, IL, U.S.A.)
Rating
[?]

Book Description Springer Science+Business Media, 1998. HRD. Condition: New. New Book. Shipped from US within 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # IQ-9780306457432

More information about this seller | Contact this seller

Buy New
US$ 376.53
Convert currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, rates & speeds

7.

Published by Springer Science+Business Media, United States (1998)
ISBN 10: 0306457431 ISBN 13: 9780306457432
New Hardcover Quantity Available: 10
Seller:
Book Depository International
(London, United Kingdom)
Rating
[?]

Book Description Springer Science+Business Media, United States, 1998. Hardback. Condition: New. 1998 ed.. Language: English. Brand new Book. In the late 1980s, it became painfully evident to the pharmaceutical industry that the old paradigm of drug discovery, which involved highly segmented drug - sign and development activities, would not produce an acceptable success rate in the future. Therefore, in the early 1990s a paradigm shift occurred in which drug design and development activities became more highly integrated. This new str- egy required medicinal chemists to design drug candidates with structural f- tures that optimized pharmacological (e. g. , high affinity and specificity for the target receptor), pharmaceutical (e. g. , solubility and chemical stability), bioph- maceutical (e. g. , cell membrane permeability), and metabolic/pharmacokinetic (e. g. , metabolic stability, clearance, and protein binding) properties. Successful implementation of this strategy requires a multidisciplinary team effort, incl- ing scientists from drug design (e. g. , medicinal chemists, cell biologists, en- mologists, pharmacologists) and drug development (e. g. , analytical chemists, pharmaceutical scientists, physiologists, and molecular biologists representing the disciplines of pharmaceutics, biopharmaceutics, and pharmacokinetics/drug metabolism). With this new, highly integrated approach to drug design now widely utilized by the pharmaceutical industry, the editors of this book have provided the sci- tific community with case histories to illustrate the nature of the interdisciplinary interactions necessary to successfully implement this new approach to drug d- covery. In the first chapter, Ralph Hirschmann provides a historical perspective of why this paradigm shift in drug discovery has occurred. Seller Inventory # APC9780306457432

More information about this seller | Contact this seller

Buy New
US$ 381.60
Convert currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, rates & speeds

8.

Published by Springer Science+Business Media, United States (1998)
ISBN 10: 0306457431 ISBN 13: 9780306457432
New Hardcover Quantity Available: 10
Seller:
The Book Depository
(London, United Kingdom)
Rating
[?]

Book Description Springer Science+Business Media, United States, 1998. Hardback. Condition: New. 1998 ed.. Language: English. Brand new Book. In the late 1980s, it became painfully evident to the pharmaceutical industry that the old paradigm of drug discovery, which involved highly segmented drug - sign and development activities, would not produce an acceptable success rate in the future. Therefore, in the early 1990s a paradigm shift occurred in which drug design and development activities became more highly integrated. This new str- egy required medicinal chemists to design drug candidates with structural f- tures that optimized pharmacological (e. g. , high affinity and specificity for the target receptor), pharmaceutical (e. g. , solubility and chemical stability), bioph- maceutical (e. g. , cell membrane permeability), and metabolic/pharmacokinetic (e. g. , metabolic stability, clearance, and protein binding) properties. Successful implementation of this strategy requires a multidisciplinary team effort, incl- ing scientists from drug design (e. g. , medicinal chemists, cell biologists, en- mologists, pharmacologists) and drug development (e. g. , analytical chemists, pharmaceutical scientists, physiologists, and molecular biologists representing the disciplines of pharmaceutics, biopharmaceutics, and pharmacokinetics/drug metabolism). With this new, highly integrated approach to drug design now widely utilized by the pharmaceutical industry, the editors of this book have provided the sci- tific community with case histories to illustrate the nature of the interdisciplinary interactions necessary to successfully implement this new approach to drug d- covery. In the first chapter, Ralph Hirschmann provides a historical perspective of why this paradigm shift in drug discovery has occurred. Seller Inventory # APC9780306457432

More information about this seller | Contact this seller

Buy New
US$ 390.52
Convert currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, rates & speeds

9.

Published by Springer (1998)
ISBN 10: 0306457431 ISBN 13: 9780306457432
New Hardcover Quantity Available: 15
Print on Demand
Seller:
Rating
[?]

Book Description Springer, 1998. Condition: New. This item is printed on demand for shipment within 3 working days. Seller Inventory # LP9780306457432

More information about this seller | Contact this seller

Buy New
US$ 395.48
Convert currency

Add to Basket

Shipping: US$ 3.51
From Germany to U.S.A.
Destination, rates & speeds

10.

Published by Springer (1998)
ISBN 10: 0306457431 ISBN 13: 9780306457432
New Hardcover Quantity Available: 1
Seller:
Irish Booksellers
(Portland, ME, U.S.A.)
Rating
[?]

Book Description Springer, 1998. Condition: New. book. Seller Inventory # M0306457431

More information about this seller | Contact this seller

Buy New
US$ 444.87
Convert currency

Add to Basket

Shipping: US$ 3.27
Within U.S.A.
Destination, rates & speeds

There are more copies of this book

View all search results for this book